Fulcrum Therapeutics Inc(FULC) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 62 full-time employees. The firm focuses on improving the lives of patients with genetically defined rare diseases. The firm have developed a product engine which identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. The firm is also engaged in developing drugs for the treatment for the root cause of muscle disorders, central nervous system disorders and blood disorders.

Current Price

$11.25

RSI

32.206

November 10, 2020
30K
-4.6M

-14.629 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.